European Society of Hyperthermic

Studies on Colon Carcinoma

Whole body hyperthermia: 
Systemic multimodal cancer therapy (42°C) combined with 5-FU and Mitomycin in metastatic colorectal carcinoma 


Prof. Dr. med. H. Riess 
Dr. med. B. Hildebrandt 
Medizinische Klinik 

Prof. Dr. med. P. Wust 
Klinik für Strahlenheilkunde 

Charité - Campus Virchow-Klinikum 
13353 Berlin 
Tel: -49-30-450-53013 or 57023/57202 

Whole body hyperthermia: 
Open, randomized, multicentric phase III trail of Oxaliplatin and 5-Fluorouracil/Leucovorin as second and third line therapy in locally advanced or metas-tatic, nonresectable colorectal carcinoma and documented progression within three months after high dose therapy with 5-Fluorouracil (25h)/Leucovorin (ARDALAN) or CPT-11 containing protocols. 


Prof. Dr. med. S. Hegewisch-Becker 
Abt. für Onkologie und Hämatologie 
Universitätsklinik Eppendorf 
Tel: +49-40-42803-3971 

Regional Hyperthermia: 
Prospective phase I/II study of regional hyperthermia and radiotherapy of hepatic metastases in colorectal carcinoma. 


Prof. Dr. med. M. Bamberg 
Dr. med. T. Hehr 
Abteilung für Strahlentherapie 
Universitätsklinikum Tübingen 
Tel: +49-7071-29-82166